Literature DB >> 19690336

Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives.

Anetta Undas1, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydłowska, Agnieszka Skubiszak, Katarzyna Ciepłuch, Wiesława Tracz.   

Abstract

We tested the hypothesis that fibrin structure/function is unfavorably altered in patients after idiopathic venous thromboembolism (VTE) and their relatives. Ex vivo plasma fibrin clot permeability, turbidimetry, and efficiency of fibrinolysis were investigated in 100 patients with first-ever VTE, including 34 with pulmonary embolism (PE), 100 first-degree relatives, and 100 asymptomatic controls with no history of thrombotic events. Known thrombophilia, cancer, trauma, and surgery were exclusion criteria. VTE patients and their relatives were characterized by lower clot permeability (P < .001), lower compaction (P < .001), higher maximum clot absorbancy (P < .001), and prolonged clot lysis time (P < .001) than controls, with more pronounced abnormalities, except maximum clot absorbance, in the patients versus relatives (all P < .01). Fibrin clots obtained for PE patients were more permeable, less compact, and were lysed more efficiently compared with deep-vein thrombosis patients (all P < .05) with no differences in their relatives. Being VTE relative, fibrinogen, and C-reactive protein were independent predictors of clot permeability and fibrinolysis time in combined analysis of controls and relatives. We conclude that altered fibrin clot features are associated with idiopathic VTE with a different profile of fibrin variables in PE. Similar features can be detected in VTE relatives. Fibrin properties might represent novel risk factors for thrombosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690336     DOI: 10.1182/blood-2009-05-222380

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  64 in total

Review 1.  Clot Structure and Implications for Bleeding and Thrombosis.

Authors:  Emily Mihalko; Ashley C Brown
Journal:  Semin Thromb Hemost       Date:  2019-10-15       Impact factor: 4.180

2.  Nanoparticle diffusion measures bulk clot permeability.

Authors:  Richard Chasen Spero; Rachel K Sircar; Ryan Schubert; Russell M Taylor; Alisa S Wolberg; Richard Superfine
Journal:  Biophys J       Date:  2011-08-17       Impact factor: 4.033

Review 3.  Fibrinogen and red blood cells in venous thrombosis.

Authors:  Maria M Aleman; Bethany L Walton; James R Byrnes; Alisa S Wolberg
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 4.  Mechanisms of fibrin polymerization and clinical implications.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Blood       Date:  2013-01-10       Impact factor: 22.113

5.  Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.

Authors:  Marissa R Martinez; Adam Cuker; Angela M Mills; Amanda Crichlow; Richard T Lightfoot; Irina N Chernysh; Chandrasekaran Nagaswami; John W Weisel; Harry Ischiropoulos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-10       Impact factor: 5.464

Review 6.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

7.  Characteristics of fibrin formation and clot stability in individuals with congenital type IIb protein C deficiency.

Authors:  J H Foley; L Ferris; K E Brummel-Ziedins
Journal:  Thromb Res       Date:  2012-01-13       Impact factor: 3.944

Review 8.  New findings on venous thrombogenesis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Hamostaseologie       Date:  2016-11-23       Impact factor: 1.778

Review 9.  Statins as a preventative therapy for venous thromboembolism.

Authors:  Alex Wallace; Hassan Albadawi; Peter Hoang; Andrew Fleck; Sailendra Naidu; Grace Knuttinen; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

10.  Smoking out the cause of thrombosis.

Authors:  Robert A Campbell; Kellie R Machlus; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.